Key result
Supervised exercise training improves peak VO2 by ~1.8 mL/kg/min in adults with congenital heart disease.
Why the study?
Adults with congenital heart disease frequently demonstrate reduced exercise tolerance, which predicts morbidity and mortality, yet evidence supporting supervised exercise training in this population remains limited.
Does a supervised exercise training programme improve exercise capacity in adults with congenital heart disease?
Cohort (n=69)
Does a supervised exercise training programme improve exercise capacity in adults with congenital heart disease?
A supervised phase II cardiac rehabilitation exercise training programme significantly improved functional capacity (peak VO₂ and METs) and ventilatory efficiency in adults with congenital heart disease without major adverse cardiovascular events.
Exercise training safely improves capacity in adults with CHD; extends evidence from acquired disease but leaves open need for larger trials.
Background Advances in medical and surgical management have substantially improved survival among patients with congenital heart disease (CHD), resulting in a rapidly expanding adult population. Despite increased longevity, adults with CHD frequently demonstrate reduced exercise tolerance, a recognised predictor of morbidity and mortality. While exercise training is a fundamental component of cardiac rehabilitation in acquired heart disease, evidence supporting its use in adults with CHD remains limited. Purpose To evaluate the impact of a supervised exercise training programme on exercise capacity and to assess its safety in adults with congenital heart disease. Methods This retrospective cohort study included adults (≥18 years) with confirmed CHD who participated in phase II cardiac rehabilitation between 2017 and 2025 (table 1) . Eligible patients were required to have completed baseline and follow-up exercise testing. A supervised exercise programme comprising 20–30 sessions of moderate-intensity aerobic training (Borg scale 12–13), combined with complementary non-aerobic exercises. Exercise capacity was assessed using peak oxygen uptake (VO₂ peak) and metabolic equivalents (METs). Adverse events during training sessions were systematically recorded. Continuous variables are presented as mean (standard deviation) or median (range), as appropriate, and categorical variables as frequencies and percentages. Pre- and post-intervention comparisons were performed using the paired t-test. A p-value <0.05 was considered statistically significant. Results A total of 69 patients were included in the analysis. The mean age of participants was 38.2 ± 15.9 years, and 57% were female. Most patients had acyanotic CHD with moderate anatomical–physiological complexity. Following the exercise programme, significant improvements were observed: peak VO₂ increased from 16.1 to 17.9 mL/kg/min (p<0.05), estimated METs increased from 5.7 to 7.8 (p<0.01), and the VE/VCO₂ slope decreased from 37.8 to 34.3 (p<0.05) (fig. 1). A total of 48 adverse events were recorded, all benign and consisting of supraventricular or ventricular ectopic beats. No major cardiovascular events, hospitalisations, or deaths occurred. Conclusion A supervised exercise training programme significantly improves exercise capacity in adults with congenital heart disease and appears to be safe, with only minor adverse events observed. These findings support the incorporation of structured cardiac rehabilitation programmes into the routine care of adults with CHD.
No takes yet. Share an insight, caveat, or question.
Rojano et al. (2026) conducted a cohort in Congenital heart disease (n=69). Supervised exercise training programme vs. Pre-intervention baseline was evaluated on Peak oxygen uptake (VO₂ peak) (p=<0.05). Supervised exercise training in adults with congenital heart disease improved peak VO2 from 16.1 to 17.9 mL/kg/min (p<0.05) and METs from 5.7 to 7.8 (p<0.01) with no major adverse events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: